Biolex Therapeutics biolex.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Biolex Therapeutics is a clinical-stage biopharmaceutical company that uses the LEX System to develop follow-on biologics, hard-to-make therapeutic proteins and monoclonal antibodies that have been optimized to enhance efficacy and potency. The LEX System genetically transforms the aquatic plant Lemna to enable the production of biologic product candidates.

Biolex Therapeutics is a clinical-stage biopharmaceutical company that uses the LEX System to develop follow-on biologics, hard-to-make therapeutic proteins and monoclonal antibodies that have been optimized to enhance efficacy and potency. The LEX S...Show all

Company (Dead / Inactive)

Phone: 919-542-9901

Fax:

158 Credle Street

Pittsboro, 27312
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Biolex Therapeutics $217.2M Jul 6, 2012
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Biolex Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 26 investors

Competitors

Company Status Description Investors

Five Prime Therapeutics

South San Francisco, California, United States
IPO / Went publicFive Prime Therapeutics is a clinical-stage biotechnology company with a pipeline of antibodies and ligand traps for cancer, autoimmunity and respiratory diseases. FivePrime has differentiated discovery capabilities built on its library of secreted and extracellular human proteins, which it leverages in cell-based assays, in vivo models and receptor-ligand matching screens to identify medically relevant new targets and therapeutic proteins. FivePrime has entered into a collaboration agreement to...Show allLogin to see details

Replidyne

Louisville, Colorado, United States
IPO / Went publicReplidyne is a drug discovery and development firm focused on a new class of antibioticsLogin to see details
See all 15 competitors